Earnings Feed
Start Free
JOHNSON & JOHNSON·4

Feb 18, 9:11 PM ET

Taubert Jennifer L 4

Research Summary

AI-generated summary

Updated

JNJ EVP Jennifer Taubert Exercises Awards; Shares Withheld for Taxes

What Happened

  • Jennifer L. Taubert, EVP, WWC Innovative Medicine at Johnson & Johnson (JNJ), had long‑term incentive awards convert into common stock (vesting/conversion of RSUs and PSUs) on Feb 13 and Feb 15, 2026. A total of 32,155 shares were issued on conversion; 15,717 of those shares were withheld/disposed to cover tax withholding, generating proceeds of about $3,841,655. Separately, Taubert received new RSU awards on Feb 15, 2026 (58,809 RSUs in total) that vest over future years.

Key Details

  • Transaction dates and withholding prices:
    • Feb 13, 2026: 1,302 and 27,412 shares converted; 409 and 13,547 shares withheld at $244.55 (total withheld value ≈ $3,412,940).
    • Feb 15, 2026: 1,594 and 1,847 shares converted; 816 and 945 shares withheld at $243.45 (total withheld value ≈ $428,715).
    • Combined shares converted: 32,155. Combined shares withheld/disposed for taxes: 15,717. Combined withheld value ≈ $3,841,655.
  • Net shares added to Taubert’s holdings from these vestings: 16,438 shares (32,155 issued − 15,717 withheld).
  • New RSU awards granted on Feb 15, 2026: 54,869 RSUs and 3,940 RSUs (total 58,809 RSUs); these vest in annual installments per the company’s Long‑Term Incentive Plan.
  • Footnote context: conversions relate to RSUs/PSUs awarded under J&J’s Long‑Term Incentive Plan (grants dated Feb 13, 2023, and earlier grants); withheld shares were used to pay required taxes on vesting (tax‑withholding, code F).
  • Filing: Form 4 filed Feb 18, 2026 covering transactions on Feb 13–15, 2026. The Feb 13 transaction was reported one business day after the typical 2‑business‑day Form 4 deadline; Feb 15 transactions were reported on time.

Context

  • These transactions reflect routine vesting and tax‑withholding (derivative conversion and shares withheld for taxes), not open‑market sales or discretionary insider sales. For retail investors, purchases/awards signal compensation vesting rather than a direct bullish purchase; withheld shares to satisfy tax obligations are common and do not necessarily indicate intent to sell more shares.